Innovative Photoactivated Ruthenium Chemotherapy to treat eye cancer

European Innovation CouncilHORIZON-EICID: 101136703
EC Contribution
โ‚ฌ25,000
Consortium Size
4 orgs
Start Year
2023
โ–ถSummary

Uveal melanoma (UM) is a rare tumor of the eye

Consortium (4)